Orchard Therapeutics plc
ORTXDelisted Jan 24, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001748907
Orchard Therapeutics plc was delisted on Jan 24, 2024; its insiders filed their last Form 4 on Jan 24, 2024; 47 institutions reported holding it in 13F filings for Q4 2023, worth $122.0M in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Orchard Therapeutics plc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 47 | +16 |
| Shares | 16.6M | 12.3M | 8.85M | +4.60M (+108.0%) |
| Value | $46.9M | $14.0M | $122.0M | +$89.1M (+270.9%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (27)
Institutions that held Orchard Therapeutics plc at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (11)
Institutions that held Orchard Therapeutics plc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Deerfield Management Company, L.P. (Series C) | 316,169 | $2.44M |
| Platinum Investment Management Ltd | 248,462 | $1.92M |
| Mariner, LLC | 192,250 | $1.49M |
| Acadian Asset Management LLC | 120,658 | $936.0K |
| Citadel Advisors LLC | 95,272 | $739.3K |
| UBS Oconnor LLC | 71,010 | $551.0K |
| Stifel Financial Corp | 31,418 | $242.9K |
| Cormorant Asset Management, LP | 25,664 | $198.4K |
| Forefront Analytics, LLC | 14,183 | $109.6K |
| Global Retirement Partners, LLC | 1,000 | $8.14K |
| Royal Bank of Canada | 100 | $1.00K |
Not filed for Q4 2023 yet (1)
Institutions that held Orchard Therapeutics plc at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| CHI Advisors LLC | 12,315,654 | $14.0M |